Compare Moderna, Inc. (MRNA) vs Qurate Retail Inc Series A (QVCAQ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Moderna, Inc. vs Qurate Retail Inc Series A — how do they compare? Moderna, Inc. trades at $59.73 (market cap $23.60B), while Qurate Retail Inc Series A trades at $0.05 (market cap $698.27K). The key difference: Moderna, Inc. is far larger — about 33797.8× Qurate Retail Inc Series A's market cap, and Moderna, Inc. is trading nearer its 52-week high, Qurate Retail Inc Series A nearer its low. Which is the better fit depends on your goals.
| MRNA | QVCAQ | |
|---|---|---|
Market Cap | $23.60B | $698.27K |
Sector | Health | Consumer Cyclical |
52-Week High | $81.80 | $15.03 |
52-Week Low | $22.36 | $0.05 |
Enterprise Value | $19.70B | $4.73B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →About Qurate Retail Inc Series A
Qurate Retail Inc, through its subsidiaries, is engaged in the video and online commerce industries. Its segments include QxH, which includes QVC U.S. and HSN market and sell a wide variety of consumer products in the United States, primarily using their televised shopping programs and via the Internet through their websites and mobile applications
Read more on QVCAQ →
